Veracyte, Inc.
VCYT
Rangering i aksjer
#4361
Veracyte, Inc. operates as a diagnostics company in the United States and... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Aksjekurs
$44.93
Sist synkronisert: 2026-10-20
Markedsverdi
$3.61B
Endring (1 dag)
2.57%
Endring (1 år)
24.45%
Land
US
Handel Veracyte, Inc. (VCYT)
Kategori
Healthcare
Historikk for aksjesplitt for Veracyte, Inc. (VCYT)
Aksjen Veracyte, Inc. (symbol: VCYT) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én VCYT-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 VCYT-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én VCYT-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 VCYT-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
